InsidersTradesSigma
Discover the full directors' dealings record of 华仁药业, a listed equity based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €3.7bn. The latest transaction was disclosed on 6 February 2024 — Purchase. Among the most active insiders: 杨效东. All data is openly available.
FY ended December 2025 · cache
0 of 0 declarations